Indomethacin-loaded solid lipid nanoparticles for ocular delivery: Development, characterization, and in vitro evaluation

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 2, 2013, Pages 216-228

  Hippalgaonkar, Ketan ^a   Adelli, Goutham R ^a   Hippalgaonkar, Kanchan ^a   Repka, Michael A ^a,b   Majumdar, Soumyajit ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; GLYCEROL BEHENATE; INDOMETACIN; POLOXAMER; POLYSORBATE 80; SOLID LIPID NANOPARTICLE; SURFACTANT;

ARTICLE; CONTROLLED STUDY; CORNEA PERMEABILITY; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; IN VITRO STUDY; INSTRUMENT STERILIZATION; PARTICLE SIZE; PH; PRESSURE; ZETA POTENTIAL;

CHEMISTRY, PHARMACEUTICAL; CORNEA; DRUG DELIVERY SYSTEMS; DRUG EVALUATION; HUMANS; INDOMETHACIN; LIPIDS; NANOPARTICLES; ORGAN CULTURE TECHNIQUES;

EID: 84875034773     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0069     Document Type: Article

References (44)

1. Backensfeld, T., Muller, B.W., Wiese, M., & Seydel, J.K. Effect of cyclodextrin derivatives on indomethacin stability in aqueous solution. Pharm. Res. 7:484-490, 1990.
2. Gueudry, J., Lebel, H., & Muraine, M. Severe corneal complications associated with topical indomethacin use. Br. J. Ophthalmol. 94:133-134, 2010.
3. Chetoni, P., Panichi, L., Burgalassi, S., Benelli, U., and Saettone, M.F. Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution. J. Ocul. Pharmacol. Ther. 16:363-372, 2000.
4. Yamaguchi, M., Ueda, K., Isowaki, A., Ohtori, A., Takeuchi, H., Ohguro, N., & Tojo, K. Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid. Biol. Pharm. Bull. 32:1266-1271, 2009.
5. Muchtar, S., Abdulrazik, M., Frucht-Pery, J., & Benita, S. Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea. J. Control. Release. 44:55-64, 1997.
6. Sanders, D.R., Goldstick, B., Kraff, C., Hutchins, R., Bernstein, M.S., & Evans, M.A. Aqueous penetration of oral and topical indomethacin in humans. Arch. Ophthalmol. 101:1614-1616, 1983.
7. Calvo, P., Vila-Jato, J.L., & Alonso, M.J. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J. Pharm. Sci. 85:530-536, 1996.
8. Klang, S., Abdulrazik, M., & Benita, S. Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution. Pharm. Dev. Technol. 5:521-532, 2000.
9. Kearse, E.C., & Green, K. Effect of vehicle upon in vitro transcorneal permeability and intracorneal content of Delta9- tetrahydrocannabinol. Curr. Eye Res. 20:496-501, 2000.
10. Tomida, I., Pertwee, R.G., & Azuara-Blanco, A. Cannabinoids and glaucoma. Br. J. Ophthalmol. 88:708-713, 2004.
11. Muller, R.H., Mader, K., & Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery -A review of the state of the art. Eur. J. Pharm. Biopharm. 50:161-177, 2000.
12. Wissing, S.A., Kayser, O., & Muller, R.H. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 56:1257-1272, 2004.
13. Rawat, M., Singh, D., & Saraf, S. Lipid carriers: a versatile delivery vehicle for proteins and peptides. Yakugaku Zasshi 128:269-280, 2008.
14. Uner, M., & Yener, G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomedicine 2:289-300, 2007.
15. Manjunath, K., Reddy, J.S., & Venkateswarlu, V. Solid lipid nanoparticles as drug delivery systems. Methods Find. Exp. Clin. Pharmacol. 27:127-144, 2005.
16. Gokce, E.H., Sandri, G., Bonferoni, M.C., Rossi, S., Ferrari, F., Guneri, T., & Caramella, C. Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int. J. Pharm. 364:76-86, 2008.
17. Souto, E.B., Doktorovova, S., Gonzalez-Mira, E., Egea, M.A., and Garcia, M.L. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. Curr. Eye Res. 35:537-552, 2010.
18. Dimitrova, E., Bogdanova, S., Mitcheva, M., Tanev, I., and Minkov, E. Development of model aqueous ophthalmic solution of indomethacin. Drug Dev. Ind. Pharm. 26:1297-1301, 2000.
19. Dimitrova, E., Bogdanova, S., Minkov, E., Manolova, N., Raschkov, I., Koleva, M., & Mihailova, S. High-molecular weight polyoxyethylene as an additive in ophthalmic solutions. Int. J. Pharm. 93:21-26, 1993.
20. Venkateswarlu, V., & Manjunath, K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Release. 95:627-638, 2004.
21. Mehnert, W., & Mader, K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47:165-196, 2001.
22. Muller, R.H., & Keck, C.M. Challenges and solutions for the delivery of biotech drugs -A review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol. 113:151-170, 2004.
23. Trotta, M., Pattarino, F., & Ignoni, T. Stability of drugcarrier emulsions containing phosphatidylcholine mixtures. Eur. J. Pharm. Biopharm. 53:203-208, 2002.
24. Goppert, T.M., & Muller, R.H. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J. Drug Target. 13:179-187, 2005.
25. Abdelbary, G., & Fahmy, R.H. Diazepam-loaded solid lipid nanoparticles: design and characterization. AAPS PharmSciTech. 10:211-219, 2009.
26. Schwarz, C., & Mehnert, W. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J. Microencapsul. 16:205-213, 1999.
27. Castelli, F., Puglia, C., Sarpietro, M.G., Rizza, L., & Bonina, F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int. J. Pharm. 304:231-238, 2005.
28. Kaur, I.P., & Kanwar, M. Ocular preparations: the formulation approach. Drug Dev. Ind. Pharm. 28:473-493, 2002.
29. Kaur, I.P., Chhabra, S., & Aggarwal, D. Role of cyclodextrins in ophthalmics. Curr. Drug Deliv. 1:351-360, 2004.
30. Loftsson, T., & StefÃnsson, E. Effect of cyclodextrins on topical drug delivery to the eye. Drug Dev. Ind. Pharm. 23:473-481, 1997.
31. Loftsson, T., & Stefansson, E. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol. Scand. 80:144-150, 2002.
32. Seyfoddin, A., Shaw, J., & Al-Kassas, R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv. 17:467-489, 2010.
33. Backensfeld, T., Müller, B.W., & Kolter, K. Interaction of NSA with cyclodextrins and hydroxypropyl cyclodextrin derivatives. Int. J. Pharm. 74:85-93, 1991.
34. Reddy, L.H., & Murthy, R.S. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPS PharmSciTech. 6:E158-E166, 2005.
35. zurMuhlen, A., Schwarz, C., & Mehnert, W. Solid lipid nanoparticles (SLN) for controlled drug delivery -drug release and release mechanism. Eur. J. Pharm. Biopharm. 45: 149-155, 1998.
36. Bunjes, H., Westesen, K., & Koch, M.H.J. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int. J. Pharm. 129:159-173, 1996.
37. Lim, S.J., & Kim, C.K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int. J. Pharm. 243:135-146, 2002.
38. Nanda, K.K., Sahu, S.N., & Behera, S.N. Liquid-drop model for the size-dependent melting of low-dimensional systems. Phys. Rev. A 66:013208, 2002.
39. Reddy, L.H., Vivek, K., Bakshi, N., & Murthy, R.S. Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. Pharm. Dev. Technol. 11:167-177, 2006.
40. Jarvinen, T., Pate, D.W., & Laine, K. Cannabinoids in the treatment of glaucoma. Pharmacol. Ther. 95:203-220, 2002.
41. Hippalgaonkar, K., Gul, W., ElSohly, M.A., Repka, M.A., and Majumdar, S. Enhanced solubility, stability, and transcorneal permeability of delta-8-tetrahydrocannabinol in the presence of cyclodextrins. AAPS PharmSciTech. 12:723-731, 2011.
42. Majumdar, S., Hippalgaonkar, K., & Repka, M.A. Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea. Int. J. Pharm. 348:175-178, 2008.
43. Sandri, G., Bonferoni, M.C., Gokce, E.H., Ferrari, F., Rossi, S., Patrini, M., & Caramella, C. Chitosan-Associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems. J. Microencapsul. 27:735-746, 2010.
44. Yuan, H., Miao, J., Du, Y.Z., You, J., Hu, F.Q., & Zeng, S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int. J. Pharm. 348:137-145, 2008.